Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer.
about
Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instability.Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionEpidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximabAberrant methylation of ERBB pathway genes in sporadic colorectal cancer.Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.Transcriptional control analyses of the Xiphophorus melanoma oncogene.Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.Epigenetic modification suppresses proliferation, migration and invasion of urothelial cancer cell lines.Genetic-and-Epigenetic Interspecies Networks for Cross-Talk Mechanisms in Human Macrophages and Dendritic Cells during MTB Infection.Targeting EGFR resistance networks in head and neck cancer.Cause and consequences of genetic and epigenetic alterations in human cancer.DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.Integrated analysis of genetic and epigenetic alterations in cancer.ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer.EGFR in melanoma: clinical significance and potential therapeutic target.Chromosome 7 aneusomy in metaplastic breast carcinomas with chondroid, squamous, and spindle-cell differentiation.Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.[Relationship between EGFR Promoter Region Methylation and Secondary Resistance Which may be Induced by Gefitinib].DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum-Implications for the Choice of Circulating Tumour DNA Methylation Markers
P2860
Q33912974-5C1CC72F-B5FC-4D4B-AF27-149ADDD7D450Q34119133-001F7BFB-6C9C-4B9F-89ED-B2CCEADC6258Q34365668-980B4308-9430-41FE-8867-D28692BFD950Q34984574-D698CCBB-666B-47EB-89EF-56E8FC62BEE8Q35034638-7F21C956-B1F6-403C-B50C-27D7E5FC25E7Q35042323-061D530A-C3CF-4036-89B9-1099A509EE51Q35546945-917F9A50-6D5A-49F6-BC28-F6452AE0DFAEQ35800058-567EAA48-6290-4BE9-BB1E-846F6C3388A7Q35824890-5E4A5DC1-ED39-491D-A8CF-3E785E3D20EFQ36214341-5D2BDDF8-EF3A-4A0F-8BD9-F83B2589B360Q36327541-E91EDF1A-264F-447F-80D1-2871E5D9C254Q36955099-EA38D4D0-B83B-4D13-93D7-46D8AD004BBDQ37205264-920030C6-4C0D-43E4-9736-109B7ED20DDEQ37345281-912E7F1F-2078-4B8C-BAAA-8C1F019EB269Q37405633-B2507D20-A20B-4B75-B66C-6CD8996F1F81Q37511752-DF2F35D7-4A9B-4AC4-8E17-B684B5A21156Q37702047-A7F7BA37-6DD1-453C-94A8-B8E2229EBFE2Q37725589-BCD37DAE-1178-4BEA-97D6-D592DCDF9EEFQ37962001-E4160385-E66B-4D35-AD48-573D1B7B1809Q38263000-3A0C3B13-B483-4FE5-AB08-FD94B87DFF52Q38336376-BCF99FB0-C31D-4D89-B48E-626CE3C2C27FQ39586032-4FCC73EF-2095-42DE-B233-EC2A7D694FFCQ42453112-A9D30336-601B-4963-AB46-1F5360125D83Q46077273-34C09257-EFA4-431C-8839-2640EA01A97BQ48413806-E2E0F63D-EFCB-4757-8A7D-6FE066316F9BQ53777182-09A27414-2253-4BB2-A3F4-A95DCA93E6D9Q54164031-510C4C65-925E-4B61-8589-E2DAF70D532FQ57390777-57C1CC5C-4F34-4E03-B6CF-157A0C18D519
P2860
Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer.
@en
type
label
Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer.
@en
prefLabel
Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer.
@en
P2093
P356
P1476
Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer
@en
P2093
Alberto J Montero
C Marcela Díaz-Montero
Emile M Youssef
Lanlan Shen
Marcos Estecio
P304
P356
10.4161/CBT.5.11.3299
P577
2006-11-19T00:00:00Z